Aarey Drugs & Pharmaceuticals

Aarey Drugs & Pharmaceuticals Limited operates in the pharmaceutical sector, specializing in the manufacturing of Active Pharmaceutical Ingredients (API) and Bulk Drugs for varied industrial uses. Its guiding philosophy is centered on creating long-term value for shareholders while carefully balancing the interests of other stakeholders like employees, creditors, and the society at large. A key principle of its operations involves integrating economic, environmental, and social objectives into its business strategy and growth to ensure sustainable development and responsible conduct. The company manufactures crucial drug intermediates and is involved in making Active Pharma Ingredients including Metformin HCL, Mefenamic Acid, and Doxophylline for the healthcare industry. Its future strategy includes increasing the production capacity of all products and implementing backward and forward integration for greater control over its supply chain. The company operates in a healthy industrial sector where the market for its product mix is currently expanding at a rate of over 6% per year.;